Share Price and Basic Stock Data
Last Updated: February 2, 2026, 3:18 pm
| PEG Ratio | 0.73 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
20 Microns Ltd operates in the mining and minerals sector, focusing on manufacturing and selling a variety of industrial minerals. The company reported a sales figure of ₹702 Cr for the fiscal year ending March 2023, which rose to ₹777 Cr for FY 2024 and is anticipated to reach ₹913 Cr for FY 2025. The latest quarterly sales for September 2023 stood at ₹200 Cr, reflecting a consistent upward trend in revenue generation. This growth trajectory is indicative of the company’s ability to enhance its market presence and operational efficiency. Over the years, the sales have shown a robust increase from ₹327 Cr in FY 2014 to the current levels, demonstrating a compound annual growth rate that significantly outpaces typical sector growth rates. This performance can be attributed to strategic investments and a focus on expanding production capacities, positioning the company favorably within the competitive landscape of the mining industry.
Profitability and Efficiency Metrics
20 Microns Ltd has recorded a commendable operating profit margin (OPM) of 14% for FY 2024, slightly declining from 13% in FY 2023. The profit before tax for FY 2024 was ₹77 Cr, with a net profit of ₹56 Cr, reflecting a net profit margin of 6.84%. These profitability metrics indicate a stable operational framework, with the company managing its expenses effectively amidst fluctuating market conditions. The interest coverage ratio stood at 6.67x, highlighting the company’s strong ability to cover interest obligations, which is well above typical sector averages. The return on equity (ROE) was reported at 16.3%, while the return on capital employed (ROCE) was 19.2%, both indicating efficient use of shareholder funds and capital. However, the cash conversion cycle (CCC) of 126 days suggests potential inefficiencies in managing receivables and inventory, which could be an area for improvement.
Balance Sheet Strength and Financial Ratios
The balance sheet of 20 Microns Ltd reflects a solid financial foundation, with total assets reported at ₹715 Cr for FY 2025. The company’s borrowings stood at ₹165 Cr, resulting in a low debt-to-equity ratio of 0.35, indicating prudent financial management and minimal reliance on debt financing. Reserves have increased to ₹437 Cr, bolstering the company’s equity base and providing a buffer for future investments or downturns. The price-to-book value (P/BV) ratio is currently at 1.57x, suggesting that the stock may be trading at a premium compared to its book value, which can be a positive signal for investors. Additionally, the current ratio of 1.71x indicates adequate liquidity to meet short-term obligations. However, the inventory turnover ratio of 6.70x may imply a need for better inventory management practices to enhance cash flow.
Shareholding Pattern and Investor Confidence
As of September 2025, 20 Microns Ltd has a diverse shareholding structure, with promoters holding 45.04% of the shares, reflecting a strong insider commitment to the company’s strategy and growth. The public holds 54.52%, indicating a healthy level of retail investor interest. Foreign institutional investors (FIIs) have decreased their stake to 0.26%, while domestic institutional investors (DIIs) hold a modest 0.17%. This decline in FII interest may raise concerns regarding international confidence in the stock, though the consistent rise in the number of shareholders, which has increased to 38,301, reflects growing local investor interest. The company’s dividend payout ratio for FY 2025 is reported at 7.07%, showcasing a commitment to returning value to shareholders, although this is relatively low, indicating a potential for reinvestment into the business.
Outlook, Risks, and Final Insight
Looking ahead, 20 Microns Ltd is well-positioned for growth, supported by its robust financial metrics and increasing sales figures. However, risks remain, including potential fluctuations in raw material prices and global market demand, which could impact profitability. Additionally, the company’s relatively high cash conversion cycle indicates operational inefficiencies that need to be addressed. The mining sector is also subject to regulatory risks, which could affect operational continuity. Nonetheless, if the company can maintain its growth trajectory and improve operational efficiencies, it may continue to enhance shareholder value. The balance between growth and risk management will be crucial in navigating the competitive landscape. Overall, 20 Microns Ltd presents a compelling investment opportunity, contingent upon its ability to leverage its strengths while mitigating inherent risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ganesha Ecoverse Ltd | 59.4 Cr. | 24.2 | 45.0/24.2 | 21.5 | 0.00 % | 7.18 % | 9.49 % | 10.0 | |
| Foundry Fuel Products Ltd | 4.34 Cr. | 5.41 | 7.09/4.83 | 1.66 | 0.00 % | % | % | 10.0 | |
| Deccan Gold Mines Ltd | 2,569 Cr. | 130 | 162/81.2 | 10.3 | 0.00 % | 21.1 % | 14.2 % | 1.00 | |
| Asi Industries Ltd | 225 Cr. | 25.0 | 45.0/23.2 | 8.65 | 38.9 | 1.60 % | 9.88 % | 7.01 % | 1.00 |
| Anmol India Ltd | 66.8 Cr. | 11.8 | 23.2/11.4 | 8.58 | 20.2 | 0.00 % | 9.81 % | 6.70 % | 10.0 |
| Industry Average | 50,973.08 Cr | 564.59 | 17.52 | 97.99 | 1.51% | 19.57% | 16.87% | 5.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 188 | 155 | 173 | 191 | 200 | 175 | 212 | 231 | 240 | 215 | 227 | 247 | 231 |
| Expenses | 164 | 138 | 153 | 164 | 170 | 153 | 186 | 201 | 209 | 188 | 199 | 216 | 199 |
| Operating Profit | 23 | 17 | 21 | 26 | 30 | 22 | 27 | 30 | 31 | 26 | 29 | 32 | 32 |
| OPM % | 12% | 11% | 12% | 14% | 15% | 13% | 12% | 13% | 13% | 12% | 13% | 13% | 14% |
| Other Income | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | -0 | 1 | 2 |
| Interest | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 5 | 5 | 4 |
| Depreciation | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 16 | 10 | 13 | 20 | 22 | 15 | 19 | 24 | 23 | 17 | 19 | 23 | 23 |
| Tax % | 26% | 27% | 29% | 25% | 28% | 25% | 29% | 26% | 27% | 23% | 20% | 26% | 26% |
| Net Profit | 12 | 7 | 9 | 15 | 16 | 12 | 14 | 18 | 16 | 13 | 15 | 17 | 17 |
| EPS in Rs | 3.36 | 2.09 | 2.64 | 4.23 | 4.54 | 3.25 | 3.87 | 5.06 | 4.65 | 3.65 | 4.31 | 4.78 | 4.93 |
Last Updated: January 2, 2026, 4:41 pm
Below is a detailed analysis of the quarterly data for 20 Microns Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 231.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Jun 2025) to 231.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Sep 2025, the value is 199.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 216.00 Cr. (Jun 2025) to 199.00 Cr., marking a decrease of 17.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 32.00 Cr..
- For OPM %, as of Sep 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Jun 2025) to 14.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Jun 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 23.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 17.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.93. The value appears strong and on an upward trend. It has increased from 4.78 (Jun 2025) to 4.93, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 327 | 356 | 357 | 392 | 427 | 480 | 529 | 484 | 613 | 702 | 777 | 913 | 920 |
| Expenses | 297 | 326 | 310 | 337 | 367 | 411 | 463 | 425 | 534 | 616 | 672 | 796 | 802 |
| Operating Profit | 31 | 30 | 46 | 56 | 60 | 69 | 66 | 59 | 79 | 86 | 106 | 117 | 118 |
| OPM % | 9% | 8% | 13% | 14% | 14% | 14% | 12% | 12% | 13% | 12% | 14% | 13% | 13% |
| Other Income | 2 | 4 | 4 | 2 | 1 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 3 |
| Interest | 24 | 27 | 25 | 24 | 22 | 22 | 22 | 25 | 20 | 18 | 16 | 18 | 19 |
| Depreciation | 11 | 11 | 10 | 10 | 10 | 10 | 13 | 14 | 14 | 14 | 14 | 18 | 20 |
| Profit before tax | -2 | -3 | 14 | 23 | 28 | 38 | 35 | 22 | 48 | 57 | 77 | 83 | 82 |
| Tax % | 19% | -16% | 24% | 31% | 32% | 35% | 30% | -6% | 27% | 27% | 27% | 24% | |
| Net Profit | -2 | -2 | 11 | 16 | 19 | 25 | 24 | 23 | 35 | 42 | 56 | 62 | 62 |
| EPS in Rs | -0.68 | -0.74 | 3.11 | 4.49 | 5.34 | 7.08 | 6.84 | 6.51 | 9.80 | 11.85 | 15.89 | 17.68 | 17.67 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 14% | 0% | 9% | 0% | 0% | 6% | 8% | 7% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 650.00% | 45.45% | 18.75% | 31.58% | -4.00% | -4.17% | 52.17% | 20.00% | 33.33% | 10.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | 650.00% | -604.55% | -26.70% | 12.83% | -35.58% | -0.17% | 56.34% | -32.17% | 13.33% | -22.62% |
20 Microns Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 21% |
| 3 Years: | 23% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 51% |
| 3 Years: | 30% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 16% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: September 4, 2025, 9:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:52 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 57 | 54 | 70 | 107 | 126 | 150 | 170 | 197 | 234 | 276 | 335 | 412 | 437 |
| Borrowings | 177 | 165 | 163 | 152 | 134 | 124 | 119 | 104 | 123 | 108 | 121 | 165 | 163 |
| Other Liabilities | 77 | 98 | 83 | 86 | 98 | 112 | 137 | 133 | 140 | 121 | 114 | 120 | 123 |
| Total Liabilities | 328 | 333 | 334 | 363 | 376 | 404 | 444 | 452 | 514 | 523 | 588 | 715 | 742 |
| Fixed Assets | 158 | 151 | 151 | 177 | 185 | 195 | 201 | 203 | 207 | 213 | 212 | 284 | 283 |
| CWIP | 9 | 7 | 4 | 7 | 8 | 4 | 11 | 3 | 5 | 8 | 12 | 9 | 21 |
| Investments | 1 | 1 | 1 | 2 | 3 | 4 | 2 | 6 | 9 | 9 | 17 | 25 | 25 |
| Other Assets | 160 | 174 | 178 | 177 | 179 | 201 | 230 | 240 | 293 | 293 | 347 | 396 | 414 |
| Total Assets | 328 | 333 | 334 | 363 | 376 | 404 | 444 | 452 | 514 | 523 | 588 | 715 | 742 |
Below is a detailed analysis of the balance sheet data for 20 Microns Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Reserves, as of Sep 2025, the value is 437.00 Cr.. The value appears strong and on an upward trend. It has increased from 412.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 165.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 742.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 715.00 Cr. (Mar 2025) to 742.00 Cr., marking an increase of 27.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 283.00 Cr.. The value appears to be declining and may need further review. It has decreased from 284.00 Cr. (Mar 2025) to 283.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Other Assets, as of Sep 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 414.00 Cr., marking an increase of 18.00 Cr..
- For Total Assets, as of Sep 2025, the value is 742.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 742.00 Cr., marking an increase of 27.00 Cr..
Notably, the Reserves (437.00 Cr.) exceed the Borrowings (163.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -146.00 | -135.00 | -117.00 | -96.00 | -74.00 | -55.00 | -53.00 | -45.00 | -44.00 | -22.00 | -15.00 | -48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 65 | 51 | 57 | 56 | 57 | 53 | 57 | 68 | 60 | 51 | 59 | 57 |
| Inventory Days | 134 | 126 | 150 | 133 | 132 | 134 | 128 | 144 | 148 | 115 | 99 | 120 |
| Days Payable | 112 | 138 | 118 | 105 | 113 | 106 | 115 | 134 | 113 | 79 | 54 | 51 |
| Cash Conversion Cycle | 87 | 39 | 90 | 84 | 77 | 80 | 69 | 78 | 94 | 87 | 104 | 126 |
| Working Capital Days | -47 | -27 | -6 | -4 | 6 | 11 | 18 | 24 | 31 | 34 | 39 | 46 |
| ROCE % | 10% | 9% | 16% | 18% | 19% | 21% | 19% | 15% | 19% | 19% | 22% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| Diluted EPS (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| Cash EPS (Rs.) | 22.88 | 19.94 | 15.78 | 13.72 | 10.44 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 121.68 | 100.35 | 83.50 | 71.53 | 60.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 121.68 | 100.35 | 83.50 | 71.53 | 60.99 |
| Revenue From Operations / Share (Rs.) | 258.68 | 220.34 | 198.85 | 173.78 | 137.03 |
| PBDIT / Share (Rs.) | 34.33 | 30.95 | 25.13 | 23.11 | 17.29 |
| PBIT / Share (Rs.) | 29.16 | 26.88 | 21.22 | 19.24 | 13.37 |
| PBT / Share (Rs.) | 23.43 | 21.77 | 16.18 | 13.50 | 6.17 |
| Net Profit / Share (Rs.) | 17.71 | 15.87 | 11.87 | 9.85 | 6.52 |
| NP After MI And SOA / Share (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| PBDIT Margin (%) | 13.27 | 14.04 | 12.63 | 13.29 | 12.62 |
| PBIT Margin (%) | 11.27 | 12.19 | 10.66 | 11.07 | 9.76 |
| PBT Margin (%) | 9.05 | 9.88 | 8.13 | 7.76 | 4.50 |
| Net Profit Margin (%) | 6.84 | 7.20 | 5.96 | 5.66 | 4.75 |
| NP After MI And SOA Margin (%) | 6.83 | 7.21 | 5.95 | 5.64 | 4.75 |
| Return on Networth / Equity (%) | 14.52 | 15.88 | 14.24 | 13.75 | 10.71 |
| Return on Capital Employeed (%) | 20.77 | 23.69 | 21.75 | 21.90 | 17.79 |
| Return On Assets (%) | 8.72 | 9.50 | 7.98 | 6.71 | 5.07 |
| Long Term Debt / Equity (X) | 0.05 | 0.03 | 0.06 | 0.11 | 0.11 |
| Total Debt / Equity (X) | 0.35 | 0.32 | 0.34 | 0.47 | 0.40 |
| Asset Turnover Ratio (%) | 1.40 | 1.40 | 1.23 | 1.14 | 1.02 |
| Current Ratio (X) | 1.71 | 1.75 | 1.53 | 1.33 | 1.23 |
| Quick Ratio (X) | 0.98 | 1.16 | 0.88 | 0.70 | 0.68 |
| Inventory Turnover Ratio (X) | 6.70 | 3.65 | 2.92 | 2.85 | 2.63 |
| Dividend Payout Ratio (NP) (%) | 7.07 | 4.72 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.47 | 3.75 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 92.93 | 95.28 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.53 | 96.25 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.67 | 6.63 | 4.99 | 4.03 | 2.40 |
| Interest Coverage Ratio (Post Tax) (X) | 4.55 | 4.50 | 3.36 | 2.72 | 1.90 |
| Enterprise Value (Cr.) | 791.16 | 563.53 | 334.96 | 365.34 | 200.94 |
| EV / Net Operating Revenue (X) | 0.86 | 0.72 | 0.47 | 0.59 | 0.41 |
| EV / EBITDA (X) | 6.53 | 5.16 | 3.78 | 4.48 | 3.29 |
| MarketCap / Net Operating Revenue (X) | 0.74 | 0.65 | 0.37 | 0.42 | 0.25 |
| Retention Ratios (%) | 92.92 | 95.27 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.57 | 1.44 | 0.89 | 1.04 | 0.57 |
| Price / Net Operating Revenue (X) | 0.74 | 0.65 | 0.37 | 0.42 | 0.25 |
| EarningsYield | 0.09 | 0.11 | 0.15 | 0.13 | 0.18 |
After reviewing the key financial ratios for 20 Microns Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 22.88. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 22.88, marking an increase of 2.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 258.68. It has increased from 220.34 (Mar 24) to 258.68, marking an increase of 38.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 34.33. This value is within the healthy range. It has increased from 30.95 (Mar 24) to 34.33, marking an increase of 3.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 29.16. This value is within the healthy range. It has increased from 26.88 (Mar 24) to 29.16, marking an increase of 2.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.43. This value is within the healthy range. It has increased from 21.77 (Mar 24) to 23.43, marking an increase of 1.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.71. This value is within the healthy range. It has increased from 15.87 (Mar 24) to 17.71, marking an increase of 1.84.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For PBDIT Margin (%), as of Mar 25, the value is 13.27. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 13.27, marking a decrease of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 11.27. This value is within the healthy range. It has decreased from 12.19 (Mar 24) to 11.27, marking a decrease of 0.92.
- For PBT Margin (%), as of Mar 25, the value is 9.05. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 9.05, marking a decrease of 0.83.
- For Net Profit Margin (%), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 7.20 (Mar 24) to 6.84, marking a decrease of 0.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.83. This value is below the healthy minimum of 8. It has decreased from 7.21 (Mar 24) to 6.83, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.52. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 14.52, marking a decrease of 1.36.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.77. This value is within the healthy range. It has decreased from 23.69 (Mar 24) to 20.77, marking a decrease of 2.92.
- For Return On Assets (%), as of Mar 25, the value is 8.72. This value is within the healthy range. It has decreased from 9.50 (Mar 24) to 8.72, marking a decrease of 0.78.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.35, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.40. There is no change compared to the previous period (Mar 24) which recorded 1.40.
- For Current Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.71, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.98, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.70. This value is within the healthy range. It has increased from 3.65 (Mar 24) to 6.70, marking an increase of 3.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.07. This value is below the healthy minimum of 20. It has increased from 4.72 (Mar 24) to 7.07, marking an increase of 2.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 20. It has increased from 3.75 (Mar 24) to 5.47, marking an increase of 1.72.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.93. This value exceeds the healthy maximum of 70. It has decreased from 95.28 (Mar 24) to 92.93, marking a decrease of 2.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.53. This value exceeds the healthy maximum of 70. It has decreased from 96.25 (Mar 24) to 94.53, marking a decrease of 1.72.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 6.63 (Mar 24) to 6.67, marking an increase of 0.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.55. This value is within the healthy range. It has increased from 4.50 (Mar 24) to 4.55, marking an increase of 0.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 791.16. It has increased from 563.53 (Mar 24) to 791.16, marking an increase of 227.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.86, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 6.53, marking an increase of 1.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
- For Retention Ratios (%), as of Mar 25, the value is 92.92. This value exceeds the healthy maximum of 70. It has decreased from 95.27 (Mar 24) to 92.92, marking a decrease of 2.35.
- For Price / BV (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.57, marking an increase of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.09, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 20 Microns Ltd:
- Net Profit Margin: 6.84%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.77% (Industry Average ROCE: 19.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.52% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.55
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.16 (Industry average Stock P/E: 17.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.35
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.84%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Mining/Minerals | 9/10, GIDC Industrial Estate, Waghodia, Vadodra District Gujarat 391760 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh C Parikh | Chairman & Managing Director |
| Mr. Atil C Parikh | Managing Director & CEO |
| Mrs. Sejal R Parikh | Whole Time Director |
| Dr. Ajay I Ranka | Independent Director |
| Mr. Jaideep B Verma | Independent Director |
| Dr. Sivaram Swaminathan | Independent Director |
| Mr. Dukhabandhu Rath | Independent Director |
| Mr. Prem Kumar Taneja | Additional Director |
FAQ
What is the intrinsic value of 20 Microns Ltd?
20 Microns Ltd's intrinsic value (as of 02 February 2026) is ₹174.63 which is 3.33% higher the current market price of ₹169.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹595 Cr. market cap, FY2025-2026 high/low of ₹284/158, reserves of ₹437 Cr, and liabilities of ₹742 Cr.
What is the Market Cap of 20 Microns Ltd?
The Market Cap of 20 Microns Ltd is 595 Cr..
What is the current Stock Price of 20 Microns Ltd as on 02 February 2026?
The current stock price of 20 Microns Ltd as on 02 February 2026 is ₹169.
What is the High / Low of 20 Microns Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of 20 Microns Ltd stocks is ₹284/158.
What is the Stock P/E of 20 Microns Ltd?
The Stock P/E of 20 Microns Ltd is 9.16.
What is the Book Value of 20 Microns Ltd?
The Book Value of 20 Microns Ltd is 129.
What is the Dividend Yield of 20 Microns Ltd?
The Dividend Yield of 20 Microns Ltd is 0.73 %.
What is the ROCE of 20 Microns Ltd?
The ROCE of 20 Microns Ltd is 19.2 %.
What is the ROE of 20 Microns Ltd?
The ROE of 20 Microns Ltd is 16.3 %.
What is the Face Value of 20 Microns Ltd?
The Face Value of 20 Microns Ltd is 5.00.